LBA03: Late-Breaking Abstracts III - Cancer

Podium Session Moderator(s)

• AK

  Anant Kumar, MD (he/him/his)

  Chairman
  Max Superspeciality Hospital, Saket , New Delhi
• 

  Nazih Khater, MD, FACS

  Associate Professor of Urology

Presentations:

• 3:30 PM – 3:40 PM CST

  LBA03-12: Biology and performance of pre- and post-pembrolizumab (Pembro) Vesical Imaging-Reporting and Data System (VI-RADS) to predict the pathological response in muscle-invasive urothelial bladder cancer (MIBC): Full data analysis from a clinical trials pipeline
  

  Podium Presenter: Andrea Necchi, MD (he/him/his) – Vita-Salute San Raffaele University and IRCCS San
• 3:40 PM – 3:50 PM CST

  LBA03-01: 89Zr-DFO-girentuximab for PET/CT Imaging of Indeterminate Renal Masses - Results from Phase 3 ZIRCON Study
  

  Podium Presenter: Brian Matthew Shuch, MD – UCLA Health
• 3:50 PM – 4:00 PM CST

  LBA03-02: Survival of lymph-node-positive prostate cancer patients after radical prostatectomy on dichotomization using a maximal lymph-node-metastasis diameter of 2 mm
  

  Podium Presenter: Masashi Kato, MD
• 4:00 PM – 4:10 PM CST

  LBA03-03: Infectious and Non-infectious Complications Following Prostate Biopsy: A Randomized Clinical Trial
  

  Podium Presenter: Badar Munir Mian, MD – Albany Medical Center
• 4:10 PM – 4:20 PM CST

  LBA03-04: MRI-derived Tumor Volume as A Predictor of Biochemical Recurrence and Adverse Pathology in Patients after Radical Prostatectomy: A Propensity Score Matching Study
  

  Podium Presenter: Jian Lu, MD – Peking University Third Hospital
• 4:20 PM – 4:30 PM CST

  LBA03-05: Radiogenomics of Muscle Invasive Bladder Cancer
  

  Podium Presenter: Xingyu Chen, MD
• 4:30 PM – 4:40 PM CST

  LBA03-06: Diagnostic Accuracy of Oncuria-Detect in the Detection of Upper Tract Urothelial Tumors
  

  Podium Presenter: Hideki Furuya, PHD – Cedars-Sinai Medical Center
• 4:40 PM – 4:50 PM CST

  LBA03-07: Imperial Prostate-4 Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): Early feasibility, safety and functional outcomes from a pilot RCT
  

  Podium Presenter: Deepika Reddy, MD (she/her/hers) – Imperial College London
• 4:50 PM – 5:00 PM CST

  LBA03-08: Pembrolizumab (pembro) for Patients (pts) With High-Risk Non-Muscle-Invasive Bladder Cancer (HR NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG): Efficacy and Evaluation of Subsequent Cystectomy From Cohort B of the Phase 2 KEYNOTE-057 Study
  

  Podium Presenter: Eric Alan Singer, MD – The Ohio State University Comprehensive Cancer Center
• 5:00 PM – 5:10 PM CST

  LBA03-09: CDH12 Drives the Development of the Neuronal Subtype in MIBC
  

  Podium Presenter: Xingyu Chen, MD
• 5:10 PM – 5:20 PM CST

  LBA03-10: Role Of Intravesical Bacille Calmette Guerin(BCG) In Eradicating Asymptomatic Bacteriuria In Bladder Cancer Patients-A Prospective Study
  

  Podium Presenter: Ganesh Prasad Sankarapandian, MBBS,MS – SRI RAMAKRISHNA HOSPITAL
• 5:20 PM – 5:30 PM CST

  LBA03-11: Clinical utility of serial cell-free DNA analysis for monitoring muscle-invasive bladder cancer patients
  

  Podium Presenter: Lourdes Mengual